DGAP-News: curasan AG postpones publication of FY results 2019
Numerous patents and a broad record of scientific publications demonstrate the clinical success of the products and the highly innovative strength of curasan.
DGAP-News: curasan AG / Key word(s): Annual Results curasan AG postpones publication of FY results 2019 15.04.2020 / 10:35 The issuer is solely responsible for the content of this announcement. curasan AG postpones publication of FY results 2019 Same applies to the General Annual Meeting planned for June 25, 2020. On 24 February, 2020, curasan AG had applied for povisional insolvency proceedings at the Aschaffenburg District Court due to overindebtedness of the company.
15.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | curasan AG |
Lindigstraße 4 | |
63801 Kleinostheim | |
Germany | |
Phone: | 06027/40 900 0 |
Fax: | 06027/40 900 29 |
E-mail: | [email protected] |
Internet: | www.curasan.de |
ISIN: | DE000A2YPGM4 |
WKN: | A2YPGM |
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1021773 |
End of News | DGAP News Service |
|
1021773 15.04.2020